AI in genomics industry

PORTLAND, OREGON, UNITED STATES, May 25, 2023 /EINPresswire.com/ -- According to the report, the global AI in genomics industry generated $346.3 million in 2021, and is anticipated to generate $9.8 billion by 2031, witnessing a CAGR of 40.6% from 2022 to 2031. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.

Key Takeaways:

Market Growth: The AI in genomics market has experienced significant growth in recent years and is expected to continue expanding. The convergence of artificial intelligence (AI) and genomics has opened up new possibilities for understanding genetic data and accelerating genomic research.

Precision Medicine: AI in genomics plays a crucial role in advancing precision medicine. By analyzing vast amounts of genomic data, AI algorithms can identify patterns and associations that help in diagnosing diseases, predicting treatment responses, and developing personalized therapies.

Data Analysis and Interpretation: Genomics generates massive amounts of complex data, and AI tools are instrumental in managing and analyzing this information. AI algorithms can handle large-scale genomic data sets, extract meaningful insights, and facilitate the interpretation of genomic variations and their potential implications.

Drug Discovery and Development: AI in genomics is revolutionizing the drug discovery and development process. Machine learning models can identify new drug targets, predict drug efficacy and toxicity, and optimize drug candidates. This accelerates the development of novel therapies and reduces the time and cost associated with bringing new drugs to market.

Genomic Sequencing and Genotyping: AI technologies have significantly enhanced genomic sequencing and genotyping techniques. AI algorithms can improve the accuracy and efficiency of DNA sequencing, identify genetic variations, and provide valuable information for research, clinical diagnosis, and genetic counseling.

Data Security and Privacy: As genomics involves highly sensitive and personal information, data security and privacy are of paramount importance. AI in genomics must ensure robust security measures and comply with ethical guidelines and regulations to protect individual privacy and prevent unauthorized access or misuse of genomic data.

Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/11921

Market Drivers:

Increasing Genomic Data Volume: The advancements in genomic sequencing technologies have led to a significant increase in the volume of genomic data being generated. AI algorithms and tools are needed to efficiently handle and analyze these vast amounts of data, extract meaningful insights, and make sense of complex genomic variations.

Precision Medicine and Personalized Healthcare: Precision medicine aims to tailor medical treatments to individual patients based on their genetic makeup and other factors. AI in genomics plays a vital role in analyzing genomic data to identify disease markers, predict treatment responses, and develop personalized therapeutic approaches. The potential to improve patient outcomes and reduce healthcare costs is a strong driver for the adoption of AI in genomics.

Market Segmentation:

Technology: This segmentation is based on the different AI technologies used in genomics applications. It may include machine learning, deep learning, natural language processing (NLP), computer vision, and other AI techniques specifically tailored for genomics data analysis.

Application: This segmentation focuses on the specific areas where AI is applied in genomics. It can include drug discovery and development, precision medicine, genomic sequencing and genotyping, diagnostics and disease risk assessment, biomarker discovery, gene expression analysis, and others.

End User: This segmentation categorizes the market based on the end users of AI in genomics. It may include pharmaceutical and biotechnology companies, research and academic institutions, healthcare providers, diagnostic laboratories, and contract research organizations (CROs).

Workflow Stage: This segmentation considers the different stages of the genomics workflow where AI is applied. It may include data preprocessing and quality control, data analysis and interpretation, variant calling and annotation, pathway analysis, and clinical decision support.

Geography: This segmentation divides the market based on regional or global geographic regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. It helps to understand regional market trends, adoption rates, and regulatory landscapes.

Request for Customization – https://www.alliedmarketresearch.com/request-for-customization/11921

Regional Growth Dynamics:

North America held the highest market share in terms of revenue in 2021, accounting for nearly half of the global AI in genomics market, and is likely to dominate the market during the forecast period. This is attributed to a large number of universities and research institutions that are at the forefront of AI research, including Stanford, MIT, Carnegie Mellon University, and the University of California, Berkeley. These institutions attract top talent from around the world and conduct cutting-edge research.

Competitive Landscape:

· IBM
· Microsoft Corporation
· NVIDIA Corporation
· Data4Cure, Inc.
· Thermo Fisher Scientific
· SOPHiA GENETICS
· FDNA INC.
· Engine Biosciences Pte. Ltd.
· Fabric Genomics
· Verge Genomics

Buy this Premium Research Report:

https://www.alliedmarketresearch.com/purchase-enquiry/11921

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the

https://www.alliedmarketresearch.com/library-access

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Allied Market Research
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.